{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:59:28Z","timestamp":1790189968178,"version":"4.1.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T00:00:00Z","timestamp":1757635200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Research program of Chengdu Health Commission","award":["2023308"],"award-info":[{"award-number":["2023308"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,12]]},"abstract":"<jats:p>This study aims to identify cross-talk genes and potential therapeutic drugs for chronic periodontitis (CP) and rheumatoid arthritis (RA) through bioinformatics analysis, highlighting their potential as biomarkers and therapeutic targets. We conducted a comprehensive bioinformatics analysis using gene expression omnibus datasets for CP (GSE10334, GSE16134) and RA (GSE55457, GSE55235) to identify common differentially expressed genes (DEGs). We analyzed the biological functions and pathway regulations of these DEGs. Common target genes were identified from the CTD and GeneCards databases, and hub genes were determined by intersecting common DEGs with these target genes. The expression levels of these hub genes were further analyzed, and their diagnostic performance was assessed using receiver operating characteristic (ROC) curves. Potential therapeutic drugs targeting these hub genes were predicted using the DGIdb database. We identified 4 hub genes (CD79A, CXCL13, SLAMF7, and CCL18) that were consistently expressed in both CP and RA. ROC analysis demonstrated that these genes had excellent diagnostic value. Further analysis using the random forest model and combined ROC confirmed their diagnostic potential. Additionally, we identified 19 potential therapeutic drugs targeting these hub genes. Our findings provide insights into the genetic overlap between RA and CP, offering potential biomarkers and therapeutic targets for personalized medicine protocols. These results lay the foundation for future disease mechanism studies and accelerated clinical drug translation.<\/jats:p>","DOI":"10.1097\/md.0000000000044358","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T21:02:14Z","timestamp":1757970134000},"page":"e44358","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Elucidation of hub cross-talk genes as potential biomarkers and drug prediction for chronic periodontitis and rheumatoid arthritis: A bioinformatics analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1838-612X","authenticated-orcid":false,"given":"Yifang","family":"Zhu","sequence":"first","affiliation":[{"name":"Clinical Laboratory, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Deng","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Xia","sequence":"additional","affiliation":[{"name":"Clinical Laboratory, Sichuan Province Orthopedic Hospital, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260923","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/idj.12630","article-title":"Current concepts in the management of periodontitis.","volume":"71","author":"Kwon","year":"2021","journal-title":"Int Dent J"},{"key":"R3-20260923","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/2211-5463.13772","article-title":"Screening and characterization of aptamers recognizing the periodontal pathogen Tannerella forsythia.","volume":"14","author":"Mizgalska","year":"2024","journal-title":"FEBS Open Bio"},{"key":"R4-20260923","doi-asserted-by":"crossref","first-page":"e0070121","DOI":"10.1128\/Spectrum.00701-21","article-title":"Diversity of Treponema denticola and other oral treponeme lineages in subjects with periodontitis and gingivitis.","volume":"9","author":"Zeng","year":"2021","journal-title":"Microbiol Spectr"},{"key":"R5-20260923","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2174\/1568026615666150414123800","article-title":"Microbial biofilms: impact on the pathogenesis of periodontitis, cystic fibrosis, chronic wounds and medical device-related infections.","volume":"15","author":"Mihai","year":"2015","journal-title":"Curr Top Med Chem"},{"key":"R6-20260923","doi-asserted-by":"crossref","first-page":"17038","DOI":"10.1038\/nrdp.2017.38","article-title":"Periodontal diseases.","volume":"3","author":"Kinane","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R7-20260923","doi-asserted-by":"crossref","first-page":"7806912","DOI":"10.1155\/2018\/7806912","article-title":"Regulatory T lymphocytes in periodontitis: a translational view.","volume":"2018","author":"Alvarez","year":"2018","journal-title":"Mediators Inflamm"},{"key":"R8-20260923","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.3390\/ijms20143394","article-title":"Th17 cells and the IL-23\/IL-17 axis in the pathogenesis of periodontitis and immune-mediated inflammatory diseases.","volume":"20","author":"Bunte","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R9-20260923","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1902\/jop.2014.140559","article-title":"Epigenetics and its role in periodontal diseases: a state-of-the-art review.","volume":"86","author":"Larsson","year":"2015","journal-title":"J Periodontol"},{"key":"R12-20260923","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis.","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"R13-20260923","doi-asserted-by":"crossref","first-page":"102400","DOI":"10.1016\/j.jaut.2019.102400","article-title":"The etiology of rheumatoid arthritis.","volume":"110","author":"Scherer","year":"2020","journal-title":"J Autoimmun"},{"key":"R14-20260923","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/prd.12300","article-title":"Periodontitis and rheumatoid arthritis: an update 2012-2017.","volume":"83","author":"Bartold","year":"2020","journal-title":"Periodontol 2000"},{"key":"R15-20260923","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.3390\/ijms20184541","article-title":"Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions.","volume":"20","author":"de Molon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R16-20260923","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1034\/j.1600-051x.2000.027004267.x","article-title":"Is there a relationship between rheumatoid arthritis and periodontal disease?","volume":"27","author":"Mercado","year":"2000","journal-title":"J Clin Periodontol"},{"key":"R18-20260923","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.1038\/s41598-019-44674-6","article-title":"Oral microbial dysbiosis linked to worsened periodontal condition in rheumatoid arthritis patients.","volume":"9","author":"Corr\u00eaa","year":"2019","journal-title":"Sci Rep"},{"key":"R19-20260923","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/08916934.2016.1261841","article-title":"The emerging roles of B cells as partners and targets in periodontitis.","volume":"50","author":"Zouali","year":"2017","journal-title":"Autoimmunity"},{"key":"R20-20260923","first-page":"533","article-title":"Exploratory research on the probable shared molecular mechanism and transcription factors between chronic periodontitis and chronic obstructive pulmonary disease.","volume":"41","author":"Zhang","year":"2023","journal-title":"Hua Xi Kou Qiang Yi Xue Za Zhi"},{"key":"R21-20260923","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.4049\/jimmunol.1302672","article-title":"Anti-CD79 antibody induces B cell anergy that protects against autoimmunity.","volume":"192","author":"Hardy","year":"2014","journal-title":"J Immunol"},{"key":"R22-20260923","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1002\/eji.201444971","article-title":"B-cell inhibition by cross-linking CD79b is superior to B-cell depletion with anti-CD20 antibodies in treating murine collagen-induced arthritis.","volume":"45","author":"Br\u00fchl","year":"2015","journal-title":"Eur J Immunol"},{"key":"R23-20260923","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.7150\/thno.65694","article-title":"Single-cell RNA landscape of the osteoimmunology microenvironment in periodontitis.","volume":"12","author":"Chen","year":"2022","journal-title":"Theranostics"},{"key":"R24-20260923","doi-asserted-by":"crossref","first-page":"711337","DOI":"10.3389\/fimmu.2021.711337","article-title":"Single-cell RNA sequencing identifies new inflammation-promoting cell subsets in Asian patients with chronic periodontitis.","volume":"12","author":"Qian","year":"2021","journal-title":"Front Immunol"},{"key":"R25-20260923","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1600-0765.2008.01042.x","article-title":"CXCL13 expression and follicular dendritic cells in relation to B-cell infiltration in periodontal disease tissues.","volume":"43","author":"Nakajima","year":"2008","journal-title":"J Periodontal Res"},{"key":"R26-20260923","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/s13075-014-0434-z","article-title":"CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic \u201cwindow of opportunity.\u201d.","volume":"16","author":"Greisen","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"R27-20260923","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1093\/rheumatology\/keab763","article-title":"CXCL13 predicts long-term radiographic status in early rheumatoid arthritis.","volume":"61","author":"Greisen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R28-20260923","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/rheumatology\/keab639","article-title":"CXCR5\/CXCL13 pathway, a key driver for migration of regulatory B10 cells, is defective in patients with rheumatoid arthritis.","volume":"61","author":"Rempenault","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"R29-20260923","doi-asserted-by":"crossref","first-page":"116037","DOI":"10.1016\/j.bcp.2024.116037","article-title":"CXCL13 promotes TNF-\u03b1 synthesis in rheumatoid arthritis through activating ERK\/p38 pathway and inhibiting miR-330-3p generation.","volume":"221","author":"Achudhan","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"R30-20260923","doi-asserted-by":"crossref","first-page":"eabf2846","DOI":"10.1126\/sciimmunol.abf2846","article-title":"SLAMF7 engagement superactivates macrophages in acute and chronic inflammation.","volume":"7","author":"Simmons","year":"2022","journal-title":"Sci Immunol"},{"key":"R31-20260923","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3390\/biomedicines10030714","article-title":"Periodontal disease augments cardiovascular disease risk biomarkers in rheumatoid arthritis.","volume":"10","author":"Panezai","year":"2022","journal-title":"Biomedicines"},{"key":"R32-20260923","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.2003.017566","article-title":"Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis, and regulation by Fc gamma receptors.","volume":"64","author":"Radstake","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R33-20260923","doi-asserted-by":"crossref","first-page":"R94","DOI":"10.1186\/ar2294","article-title":"Expression and regulation of CCL18 in synovial fluid neutrophils of patients with rheumatoid arthritis.","volume":"9","author":"Auer","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"R34-20260923","first-page":"266","article-title":"High CCL18\/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.","volume":"34","author":"Momohara","year":"2007","journal-title":"J Rheumatol"},{"key":"R35-20260923","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1136\/ard.2006.066084","article-title":"Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis.","volume":"66","author":"van Lieshout","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R36-20260923","doi-asserted-by":"crossref","first-page":"e46440","DOI":"10.1371\/journal.pone.0046440","article-title":"Gene expression profiles in paired gingival biopsies from periodontitis-affected and healthy tissues revealed by massively parallel sequencing.","volume":"7","author":"Davanian","year":"2012","journal-title":"PLoS One"},{"key":"R37-20260923","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1902\/jop.2000.71.2.202","article-title":"Fluoroquinolones in the treatment of Actinobacillus actinomycetemcomitans-associated periodontitis.","volume":"71","author":"Kleinfelder","year":"2000","journal-title":"J Periodontol"},{"key":"R38-20260923","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/dkh354","article-title":"In vitro antibacterial activity of fluoroquinolones against Porphyromonas gingivalis strains.","volume":"54","author":"Eick","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R39-20260923","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1902\/jop.2008.070493","article-title":"Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis.","volume":"79","author":"Guentsch","year":"2008","journal-title":"J Periodontol"},{"key":"R40-20260923","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.4317\/medoral.20552","article-title":"Systemic moxifloxacin vs amoxicillin\/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.","volume":"20","author":"Guzeldemir-Akcakanat","year":"2015","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R41-20260923","doi-asserted-by":"crossref","first-page":"253","DOI":"10.17219\/dmp\/133512","article-title":"Do fluoroquinolone agents produce therapeutic benefits or harmful effects in patients with periodontitis? A systematic review and meta-analysis.","volume":"58","author":"Romo","year":"2021","journal-title":"Dent Med Probl"},{"key":"R42-20260923","doi-asserted-by":"crossref","first-page":"116162","DOI":"10.1016\/j.diagmicrobio.2023.116162","article-title":"Systemic ciprofloxacin treatment of multidrug-resistant Aggregatibacter actinomycetemcomitans in severe periodontitis.","volume":"108","author":"Rams","year":"2024","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R43-20260923","doi-asserted-by":"crossref","first-page":"121063","DOI":"10.1016\/j.biomaterials.2021.121063","article-title":"Mutual-reinforcing sonodynamic therapy against Rheumatoid Arthritis based on sparfloxacin sonosensitizer doped concave-cubic rhodium nanozyme.","volume":"276","author":"Li","year":"2021","journal-title":"Biomaterials"},{"key":"R44-20260923","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/01.smj.0000254190.54327.3b","article-title":"Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate.","volume":"100","author":"Ogrendik","year":"2007","journal-title":"South Med J"},{"key":"R45-20260923","first-page":"CD007356","article-title":"Rituximab for rheumatoid arthritis.","volume":"1","author":"Lopez-Olivo","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R46-20260923","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10067-019-04699-8","article-title":"A comprehensive review of rituximab therapy in rheumatoid arthritis patients.","volume":"38","author":"Tavakolpour","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R47-20260923","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1177\/0022034521995157","article-title":"Host modulation and treatment of periodontal disease.","volume":"100","author":"Balta","year":"2021","journal-title":"J Dent Res"},{"key":"R48-20260923","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s40120-024-00616-7","article-title":"Dental adverse effects of anti-CD20 therapies.","volume":"13","author":"Bartak","year":"2024","journal-title":"Neurol Ther"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:01:50Z","timestamp":1790186510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,12]]},"references-count":44,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044358","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,12]]},"assertion":[{"value":"2025-05-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}